Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Treatment of Ulcerative Colitis for Improved Patient Outcomes and Quality of Life

Premiere Date: Wednesday, April 15, 2015

This activity offers CE credit for:

1. Physicians (CME)
2. Pharmacists (ACPE)
3. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Friday, April 15, 2016
Note: Credit Is No Longer Available

Faculty

Maria T. Abreu, MD  Director, Crohn's and Colitis Center Martin Kalser Chair in Gastroenterology Professor of Medicine Professor of Microbiology and Immunology University of Miami Miller School of Medicine Miami, FL

Raymond K. Cross, MD, MS, AGAF  Associate Professor of Medicine Division of Gastroenterology and Hepatology Director of the Inflammatory Bowel Disease Program University of Maryland School of Medicine Co-Director of the Digestive Health Center University of Maryland Medical Center Baltimore, MD

Statement of Need

Patients with ulcerative colitis are managed on long-term medications to maintain remission and mucosal healing. Patients may not understand the importance of maintaining therapy once they begin to feel better. Further, patients may experience side effects and may quit their medication or not take as prescribed. To improve patient adherence, health care professionals must explain the rationale for long-term therapy and explain how to manage side effects.

This CME Outfitters Snack features expert faculty discussing practical recommendations for patients with ulcerative colitis, including medication adherence and helpful tips on communicating with patients.

Activity Goal

This educational activity centers on the CME Outfitters Make One Change statement. This statement is crafted from pertinent quality measures or clinical guidelines as a performance challenge to all participants. The Make One Change statement for this activity is:

Improve communication and address quality of life issues regularly, to achieve patients’ documented goals, prevent symptoms from worsening, and achieve remission.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Routinely inform and educate patients with ulcerative colitis about the benefits of maintenance treatment and the importance of adherence to maintenance treatment.
• Implement individualized induction and maintenance treatment plans according to various agents’ efficacy and safety profiles and factors influencing adherence.

The following learning objectives pertain only to those requesting CNE or CPE credit:

• Routinely inform and educate patients with ulcerative colitis about the benefits of maintenance treatment and the importance of adherence to maintenance treatment.
• Implement individualized induction and maintenance treatment plans according to various agents’ efficacy and safety profiles and factors influencing adherence.

Financial Support

This activity is supported by an independent educational grant from Shire.

Target Audience

Gastroenterologists, internal medicine physicians, pharmacists, and other health care professionals who are involved in treating patients with ulcerative colitis.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-15-016-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST1981 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Abreu has disclosed that she serves as a consultant to AbbVie Inc.; Ferring Pharmaceuticals; Focus Medical Communications; GSK Holding Americas, Inc.; Hospira, Inc.; Janssen Pharmaceuticals, Inc.; Mucosal Health Board; Pfizer Inc.; Prometheus Laboratories Inc.; Salix Pharmaceuticals, Inc.; sanofi-aventis U.S. LLC; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc. She is on the advisory board of Asana Medical, Inc. She serves on the board of directors for GI Health Foundation.

Dr. Cross has disclosed that he receives grants/research support from AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Shire; and Takeda Pharmaceuticals U.S.A., Inc.. He serves as a consultant for AbbVie Inc. and Janssen Pharmaceuticals, Inc. He serves on the advisory boards of AbbVie Inc. and Janssen Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Jeffrey Helfand, DO, MS (content/peer reviewer) has nothing to disclose.

Frances Daniel, MPH (planning committee) has nothing to disclose.

Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.

Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.

Disclosures have been obtained from CME Outfitters staff: Nothing to disclose.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, and Shire do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

There is no fee to participate in or claim CME/CE credit for this activity.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).